These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8519047)

  • 21. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
    Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Caregiver burden in dementia: evaluation with a Japanese version of the Zarit caregiver burden interview].
    Hirono N; Kobayashi H; Mori E
    No To Shinkei; 1998 Jun; 50(6):561-7. PubMed ID: 9656252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebral white matter changes and rate of progression of dementia during cholinesterase inhibitor treatment: a retrospective cohort study.
    Devine ME; Fonseca JA; Walker RW; Sikdar T; Stevens T; Walker Z
    Int J Geriatr Psychiatry; 2007 Nov; 22(11):1120-6. PubMed ID: 17457951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium channel blockers and stroke.
    Inzitari D; Poggesi A
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):16-30. PubMed ID: 16640170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of CDP-choline on senile mental deterioration. Multicenter experience on 237 cases].
    Serra F; Diaspri GP; Gasbarrini A; Giancane S; Rimondi A; Tamè MR; Sakellaridis E; Bernardi M; Gasbarrini G
    Minerva Med; 1990 Jun; 81(6):465-70. PubMed ID: 2193245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of behavioral disorders in dementia with risperidone in psychogeriatric out-patients].
    Kurz A; Delius-Stute H; Rettig K; Schwalen S
    MMW Fortschr Med; 2003 Oct; 145 Suppl 3():89-95. PubMed ID: 15490773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Galantamine treatment of vascular dementia: a randomized trial.
    Auchus AP; Brashear HR; Salloway S; Korczyn AD; De Deyn PP; Gassmann-Mayer C;
    Neurology; 2007 Jul; 69(5):448-58. PubMed ID: 17664404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease.
    Leroi I; Brandt J; Reich SG; Lyketsos CG; Grill S; Thompson R; Marsh L
    Int J Geriatr Psychiatry; 2004 Jan; 19(1):1-8. PubMed ID: 14716693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of the Korean version of the Bayer activities of daily living scale.
    Choi SH; Na DL; Lee BH; Kang SJ; Ha CK; Han SH; Erzigkeit H
    Hum Psychopharmacol; 2003 Aug; 18(6):469-75. PubMed ID: 12923826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Scandinavian Multi-Infarct Dementia Trial: a double-blind, placebo-controlled trial on nimodipine in multi-infarct dementia.
    Pantoni L; Bianchi C; Beneke M; Inzitari D; Wallin A; Erkinjuntti T
    J Neurol Sci; 2000 Apr; 175(2):116-23. PubMed ID: 10831772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic effect of piracetam with nimodipine on vascular dementia after cerebral infarction.
    Zongfang Z; Wenjing L; Zhaomin C; Lei Z
    Pak J Pharm Sci; 2020 Sep; 33(5(Special)):2405-2411. PubMed ID: 33832882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical aspects of nimodipine.
    Grobe-Einsler R
    Clin Neuropharmacol; 1993; 16 Suppl 1():S39-45. PubMed ID: 8519001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of neuroleptics in the treatment of dementia in old age. A critical analysis with reference to an experiment with a long-acting oral neuroleptic (penfluridol Janssen).
    Cahn LA; Diesfeldt HF
    Psychiatr Neurol Neurochir; 1973; 76(6):411-20. PubMed ID: 4592700
    [No Abstract]   [Full Text] [Related]  

  • 35. A preliminary open trial with nimodipine in patients with cognitive impairment and leukoaraiosis.
    Pantoni L; Carosi M; Amigoni S; Mascalchi M; Inzitari D
    Clin Neuropharmacol; 1996 Dec; 19(6):497-506. PubMed ID: 8937788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The importance of nimodipine in treatment of dementia].
    Eckert A
    Pharm Unserer Zeit; 2005; 34(5):392-8. PubMed ID: 16180362
    [No Abstract]   [Full Text] [Related]  

  • 37. Global rating, symptoms, behavior, and cognitive performance as indicators of efficacy in clinical studies with nimodipine in elderly patients with cognitive impairment syndromes.
    Schmage N; Bergener M
    Int Psychogeriatr; 1992; 4 Suppl 1():89-99. PubMed ID: 1504290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A systematic review of the efficacy of donepezil hydrochloride combined with nimodipine on treating vascular dementia.
    Yang Q; Liu J; Huang KL; Wang GY; Wang MY; Tan AH; Ran SM
    Medicine (Baltimore); 2022 Aug; 101(31):e29307. PubMed ID: 35945739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapy of dementing diseases: value of calcium antagonists].
    Möller HJ
    Fortschr Med; 1993 Oct; 111(28):437-40. PubMed ID: 8282287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycosaminoglycan polysulfate in the treatment of old age dementias.
    Ban TA; Morey LC; Aguglia E; Batista R; Campanella G; Conti L; Dreyfus JF; Fjetland OK; Grossi D; Modaferri A
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(3):323-42. PubMed ID: 1862217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.